Leukoreduction of red blood cell units decreases dysregulatory micro RNAs during routine storage: An observational study with In‐silico analysis

Abstract

AbstractBackgroundRed Blood cells (RBCs) bring about harmful consequences during storage. MicroRNA (miRNA) dysregulation in stored RBCs could represent potential biomarkers of storage lesions. Although leukoreduction prevents damage to RBCs, it is uncertain whether leukoreduction of RBCs would impact the dysregulation of miRNAs during storage. This study evaluated the potential role of miRNAs for any alteration of leukoreduced (LR) and non‐leukoreduced (NLR) RBCs till 21 days of storage.Study Design and MethodsIn this prospective study, thirty male volunteers' blood was equally divided into leukoreduced RBCs (LR) and NLR RBC (NLR) bags and stored till Day 21 at 4‐60c. Selected miRNAs were quantified on Days 0 and 21. Further, bioinformatic tools were used to analyze the selected miRNAs and their predicted target genes (mRNAs) and identify the miRNA‐mRNA regulatory relationships.ResultsA significantly higher fold change values of three miRNAs (miR‐96‐5p, miR‐197‐3p, miR‐769‐3p) were observed in NLR RBCs (p < .05). A significantly higher (p < .05) expression levels of miR‐150‐5p and miR‐197‐3p were observed in NLR RBCs till 21 days of storage. Further, the correlation with mRNA quantification confirmed the regulatory role of these miRNAs upon functional pathway enrichment analysis.DiscussionA higher level of dysregulation of miRNAs was observed in NLR RBCs. Validation from In‐Silico analysis suggested the regulatory role of miRNAs in cell apoptosis, senescence, and RBC‐related signaling pathways. This indicated that stored LR RBCs would likely have better in vivo survival and function following transfusion. However, an in vivo study of miRNA in RBCs is warranted for conclusive evidence.